SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023235
Filing Date
2023-07-03
Accepted
2023-07-03 08:54:20
Documents
18
Period of Report
2023-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44054
2 ex4-1.htm EX-4.1 93383
3 ex5-1.htm EX-5.1 16960
4 ex10-1.htm EX-10.1 374414
5 ex99-1.htm EX-99.1 12225
6 ex5-1_001.jpg GRAPHIC 11231
7 ex99-1_001.jpg GRAPHIC 3824
  Complete submission text file 0001493152-23-023235.txt   840087

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20230703.xsd EX-101.SCH 3313
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20230703_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20230703_pre.xml EX-101.PRE 22379
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3311
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 231063767
SIC: 2834 Pharmaceutical Preparations